<DOC>
	<DOCNO>NCT02875626</DOCNO>
	<brief_summary>This single-center prospective study evaluate diagnostic performance safety Infracyanine woman early breast cancer whose research sentinel node ( ) combine isotopes Infracyanine .</brief_summary>
	<brief_title>Role Indocyanine Green ( ICG ) Detection Sentinel Nodes Breast Cancer</brief_title>
	<detailed_description>Visits : Screening : Complete physical gynecological examination surgical oncologist Informed sign consent form . The intervention plan within one month . Intervention : In begin intervention , periareolar injection Infracyanine carry ( Infracyanine® , 2ml 2.5mg/ml whether 3.2nM ) . The search sentinel node make use infrared camera transcutaneous visualization Secondly , data lymphoscintigraphy may communicate surgeon . The node identify SN fluorescent node / radioactive node . - All radioactive node / fluorescent delete - Reports anatomy fluorescent SN / hot Next visit : The patient review consultation month follow itervention clinical examination , collection adverse event .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>1 . Female age &gt; 18 year 2 . Invasive breast cancer ≤ 5 cm , unifocal bifocal multifocal 3 . Diagnosis confirm biopsy 4 . Breast cancer extend situ 5 . First surgical treatment 1 . Neoadjuvant chemotherapy hormone therapy . 2 . Multicentric tumor 3 . Pregnant patient 4 . Ongoing participation another clinical trial investigational drug</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>